Zacks Investment Research on MSN
NPCE receives FDA approval for AI-powered ECoG assistant for epilepsy
NeuroPace NPCE recently announced that the FDA has approved its ECoG Assistant, its first AI-driven feature to assist ...
Praxis Precision Medicines said on Monday its experimental epilepsy drug failed to meet the main goal of a mid- to late-stage study, prompting it to pause enrollment in another ongoing study while ...
14hon MSN
Praxis reassesses Vormatrigine program after pivotal epilepsy study misses primary endpoint
Praxis Precision Medicines Inc. PRAX on Monday reported results from its Phase 2/3 POWER1 study of vormatrigine for focal ...
The EpiWatch app shows high sensitivity in detecting tonic-clonic seizures in children and adults, potentially reducing SUDEP ...
Great Big Story on MSN
Katie Cooke, running beyond the limits of epilepsy
Despite living with frequent seizures, Katie Cooke refuses to let epilepsy stop her passion for running and competition.
“We had no idea she could die just like that,” James Hardwick said of his daughter Ellie ...
Epilepsy presents differently in each person. The condition has a range of symptoms that varies. Convulsions can be one sign of epilepsy. However, people often experience epilepsy without ever having ...
Shares of Praxis Precision Medicines declined after vormatrigine, a treatment the company is developing for certain seizures and epilepsy, didn't meet its primary endpoint in a recent trial. The stock ...
A viral TikTok video of Yareli Jessica Gijon experiencing seizure symptoms in class sparked conversations about epilepsy ...
Several weeks after NBC News reached out to Anthem Blue Cross Blue Shield about the denial, the insurer changed its policy to ...
If people with epilepsy could get “seizure warnings” akin to thunderstorm warnings, their neurological disorder might be less disruptive to their lives. That’s the goal driving work at the University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results